Overview

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
To collect clinical response data with the use of ertapenem in community acquired sepsis.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Anti-Infective Agents
Ertapenem